Altered Distribution of Hippocampal Interneurons in the Murine down Syndrome Model Ts65Dn.
Abstract
Down Syndrome, with an incidence of one in 800 live births, is the most common genetic alteration producing intellectual disability. We have used the Ts65Dn model, that mimics some of the alterations observed in Down Syndrome. This genetic alteration induces an imbalance between excitation and inhibition that has been suggested as responsible for the cognitive impairment present in this syndrome. The hippocampus has a crucial role in memory processing and is an important area to analyze this imbalance. In this report we have analysed, in the hippocampus of Ts65Dn mice, the expression of synaptic markers: synaptophysin, vesicular glutamate transporter-1 and isoform 67 of the glutamic acid decarboxylase; and of different subtypes of inhibitory neurons (Calbindin D-28k, parvalbumin, calretinin, NPY, CCK, VIP and somatostatin). We have observed alterations in the inhibitory neuropil in the hippocampus of Ts65Dn mice. There was an excess of inhibitory puncta and a reduction of the excitatory ones. In agreement with this observation, we have observed an increase in the number of inhibitory neurons in CA1 and CA3, mainly interneurons expressing calbindin, calretinin, NPY and VIP, whereas parvalbumin cell numbers were not affected. These alterations in the number of interneurons, but especially the alterations in the proportion of the different types, may influence the normal function of inhibitory circuits and underlie the cognitive deficits observed in DS.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In Ts65Dn hippocampus, there is a significant increase in calretinin positive neurons and no change in parvalbumin positive neurons.
“A third study also assessed the interneuron content of the hippocampus and again identified a significant increase in calretinin positive neurons with no change in parvalbumin positive neurons (Hernandez-Gonzalez et al., 2015).”
From Neurodevelopment in Down syndrome: Concordance in humans and models (2022) · cites this paper as Hernandez-Gonzalez et al., 2015
Striking conservation was found in the ratio of ExN:InN (2.17:1) and the ratio of MGE:CGE InNs (1.4:1) in both control and Ts21 samples.
“Whereas Ts21 mouse models have identified alterations in the balance of ExN and InN (43-45), we found striking conservation in the ratio of ExN:InN (2.17:1) and the ratio of MGE:CGE InNs (1.4:1) in both control and Ts21 samples (Fig. 4B).”
From Molecular and cellular processes disrupted in the early postnatal Down syndrome prefrontal cortex (2026) · cites this paper as [45]
Cites
Acsády, L., Görcs, T. J., & Freund, T. F. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00609-5 · Cited by 310 · see citing works
Disordered connectivity in the autistic brain: Challenges for the ‘new psychophysiology’
Rippon, G., Brock, J., Brown, C., & Boucher, J. (2007) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2006.03.012 · Cited by 308 · see citing works
Excitatory-inhibitory balance and critical period plasticity in developing visual cortex
Hensch, T. K., & Fagiolini, M. (2005) · Progress in Brain Research · doi:10.1016/s0079-6123(04)47009-5 · Cited by 267 · see citing works
Altered long-term potentiation in the young and old Ts65Dn mouse, a model for down syndrome
Siarey, R. J., Stoll, J., Rapoport, S. I., & Galdzicki, Z. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00157-3 · Cited by 222 · see citing works
Down's syndrome: Is there a decreased population of neurons?
Ross, M. H., Galaburda, A. M., & Kemper, T. L. (1984) · Neurology · doi:10.1212/wnl.34.7.909 · Cited by 191 · see citing works
Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions
Sturgeon, X., & Gardiner, K. J. (2011) · Mammalian Genome · doi:10.1007/s00335-011-9321-y · Cited by 117 · see citing works
Hyde, L. A., Frisone, D. F., & Crnic, L. S. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00313-2 · Cited by 108 · see citing works
Pérez-Cremades, D., Hernández, S., Blasco-Ibáñez, J. M., Crespo, C., Nacher, J., & Varea, E. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0376-9 · Cited by 85 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Xu, R., Brawner, A. T., Li, S., Liu, J.-J., Kim, H., Xue, H., Pang, Z. P., Kim, W.-Y., Hart, R. P., Liu, Y., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.04.014 · Cited by 193 · see citing works
Neurodevelopment in Down syndrome: Concordance in humans and models
Klein, J. A., & Haydar, T. F. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.941855 · Cited by 47 · see citing works
“A third study also assessed the interneuron content of the hippocampus and again identified a significant increase in calretinin positive neurons with no change in parvalbumin positive neurons (Hernandez-Gonzalez et al., 2015).”
BackgroundMolecular and cellular processes disrupted in the early postnatal Down syndrome prefrontal cortex
Risgaard, R. D., Hanthanan Arachchilage, K., Knaack, S. A., Hosseini, M., Chen, R. J., Kumarage, P., Schmidt, D. K., Huang, X., Sheng, J., Wang, C. J., et al. (2026) · Science · doi:10.1126/science.aea1549 · Cited by 12 · see citing works
- Authors
- Hernández-González, S., Ballestín, R., López-Hidalgo, R., Gilabert-Juan, J., Blasco-Ibáñez, J. M., Crespo, C., Nácher, J., & Varea, E.
- Affiliations
- Universitat de València (ES)
- Corresponding author
- Varea, Emilio
- Venue
- Neurochemical Research
- Published
- 2014-11-16
- Volume
- 40
- Issue
- 1
- Pages
- 151-164
- ISSN
- 0364-3190 (ISSN-L)
- 1573-6903
- OpenAlex
- W2036979318
- Cited by
- 41
- References
- 8
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 4 · 2022: 7 · 2021: 2 · 2020: 5 · 2019: 7 · 2018: 1 · 2017: 5 · 2016: 5 · 2015: 1
- FWCI
- 3.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neurochemical Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- Down syndrome, Ts65Dn mouse model, hippocampal interneurons, inhibitory neurons, excitatory-inhibitory imbalance, synaptic markers, synaptophysin, VGLUT1, glutamic acid decarboxylase, parvalbumin, calbindin, calretinin, neuropeptide Y, cholecystokinin, VIP, somatostatin, CA1, CA3, intellectual disability, cognitive impairment
- MeSH terms
- Animals, Calcium-Binding Proteins, Down Syndrome, Hippocampus, Interneurons, Mice, Inbred C57BL, Nerve Tissue Proteins, Neuropeptides, Synapses, Neuropil, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review